» Articles » PMID: 30992990

Exosomes from Mesenchymal Stem/stromal Cells: a New Therapeutic Paradigm

Overview
Journal Biomark Res
Publisher Biomed Central
Date 2019 Apr 18
PMID 30992990
Citations 189
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem/stromal cells (MSCs) have been demonstrated to hold great potential for the treatment of several diseases. Their therapeutic effects are largely mediated by paracrine factors including exosomes, which are nanometer-sized membrane-bound vesicles with functions as mediators of cell-cell communication. MSC-derived exosomes contain cytokines and growth factors, signaling lipids, mRNAs, and regulatory miRNAs. Increasing evidence suggests that MSC-derived exosomes might represent a novel cell-free therapy with compelling advantages over parent MSCs such as no risk of tumor formation and lower immunogenicity. This paper reviews the characteristics of MSC exosomes and their fate after in vivo administration, and highlights the therapeutic potential of MSC-derived exosomes in liver, kidney, cardiovascular and neurological disease. Particularly, we summarize the recent clinical trials performed to evaluate the safety and efficacy of MSC exosomes. Overall, this paper provides a general overview of MSC-exosomes as a new cell-free therapeutic paradigm.

Citing Articles

Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomes Attenuates Experimental Periodontitis in Mice Partly by Delivering miRNAs.

Li K, Gu X, Zhu Y, Guan N, Wang J, Wang L Int J Nanomedicine. 2025; 20:2879-2899.

PMID: 40078652 PMC: 11900796. DOI: 10.2147/IJN.S502192.


Mesenchymal stem cell-derived small extracellular vesicles reduced hepatic lipid accumulation in MASLD by suppressing mitochondrial fission.

Chen Y, Yang F, Wang Y, Shi Y, Liu L, Luo W Stem Cell Res Ther. 2025; 16(1):116.

PMID: 40045380 PMC: 11884000. DOI: 10.1186/s13287-025-04228-2.


Exosomes containing miR-148a-3p derived from mesenchymal stem cells suppress epithelial-mesenchymal transition in lens epithelial cells.

Ma J, Sun Q, Chen Y, Li J, Chen S, Luo L Stem Cells Transl Med. 2025; 14(2).

PMID: 40036306 PMC: 11878568. DOI: 10.1093/stcltm/szae091.


Mesenchymal stem cell exosome therapy: current research status in the treatment of neurodegenerative diseases and the possibility of reversing normal brain aging.

Quan J, Liu Q, Li P, Yang Z, Zhang Y, Zhao F Stem Cell Res Ther. 2025; 16(1):76.

PMID: 39985030 PMC: 11846194. DOI: 10.1186/s13287-025-04160-5.


Recent advances in adipose-derived mesenchymal stem cell-derived exosomes for regulating macrophage polarization.

Dong Z, Fu Y, Cai Z, Dai H, He Y Front Immunol. 2025; 16:1525466.

PMID: 39963133 PMC: 11830602. DOI: 10.3389/fimmu.2025.1525466.


References
1.
Bruno S, Grange C, Deregibus M, Calogero R, Saviozzi S, Collino F . Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009; 20(5):1053-67. PMC: 2676194. DOI: 10.1681/ASN.2008070798. View

2.
Chen T, Lai R, Lee M, Choo A, Lee C, Lim S . Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 2009; 38(1):215-24. PMC: 2800221. DOI: 10.1093/nar/gkp857. View

3.
Tian T, Wang Y, Wang H, Zhu Z, Xiao Z . Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J Cell Biochem. 2010; 111(2):488-96. DOI: 10.1002/jcb.22733. View

4.
Bruno S, Grange C, Collino F, Deregibus M, Cantaluppi V, Biancone L . Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One. 2012; 7(3):e33115. PMC: 3303802. DOI: 10.1371/journal.pone.0033115. View

5.
Fouraschen S, Pan Q, de Ruiter P, Farid W, Kazemier G, Kwekkeboom J . Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. Stem Cells Dev. 2012; 21(13):2410-9. DOI: 10.1089/scd.2011.0560. View